person · Reporting owner
Kliphouse Kirsten Marie
Disclosed activity across 4 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| GLOBAL PAYMENTS INCGPN · Entity 3197 | Director | May 01, 2026 | May 04, 2026 |
| LABCORP HOLDINGS INC.LH · Entity 1277 | Director | February 11, 2026 | February 13, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
GLOBAL PAYMENTS INC
Report date May 01, 2026 · Filed May 04, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 9,076 |
Reported balance
After 2026-05-01 transaction · row 1
1 source rowRow 1 · 2026-05-01 · Grant · Acquired 3,179 · Balance 9,076 F1: Represents fully-vested shares of common stock, which were granted to the reporting person as compensation for service as a non-employee director. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents fully-vested shares of common stock, which were granted to the reporting person as compensation for service as a non-employee director.
LABCORP HOLDINGS INC.
Report date February 11, 2026 · Filed February 13, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 3,160 |
Reported balance
After 2026-02-11 transaction · row 1
1 source rowRow 1 · 2026-02-11 · Exercise / conversion · Acquired 897 · Balance 3,160 F1: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock. |
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 773 |
Reported balance
After 2026-02-11 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-02-11 · Exercise / conversion · Disposed 897 · Balance 773 F1: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock. F2: The Restricted Stock Units vested fully on February 11, 2026. F3: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. |
Filing footnotes · ownership attribution and instrument terms
F1: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock.
F2: The Restricted Stock Units vested fully on February 11, 2026.
F3: This number reflects the aggregate number of Restricted Stock Units held by the reporting person.
Past disclosures · reporting ended (2)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Dun & Bradstreet Holdings, Inc.
Report date August 26, 2025 · Filed August 26, 2025
Section 16 reporting ended · disclosed 2025-08-26. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2025-08-26 transaction · row 1
1 source rowRow 1 · 2025-08-26 · Disposition to issuer · Disposed 53,579 · Balance 0 F1: Pursuant to that certain Agreement and Plan of Merger (as amended from time to time, the "Merger Agreement") dated as of March 23, 2025 by and among the Issuer, Denali Intermediate Holdings, Inc., ("Parent"), and Denali Buyer, Inc., a direct wholly owned subsidiary of Parent ("Merger Sub"), Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly owned subsidiary of Parent. F2: Pursuant to the Merger Agreement, among other things, (i) each outstanding share of the common stock of the Issuer was cancelled and converted into the right to receive $9.15 in cash per share without interest and subject to deduction for any applicable withholding taxes (the "Merger Consideration") and (ii) each outstanding restricted stock award subject to time-based or performance-based vesting conditions, whether vested or unvested, held by a member of the board of directors of the Issuer (other than the Chief Executive Officer), was converted into the right to receive the Merger Consideration plus all accumulated but unpaid dividend equivalent rights with respect to such shares. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to that certain Agreement and Plan of Merger (as amended from time to time, the "Merger Agreement") dated as of March 23, 2025 by and among the Issuer, Denali Intermediate Holdings, Inc., ("Parent"), and Denali Buyer, Inc., a direct wholly owned subsidiary of Parent ("Merger Sub"), Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly owned subsidiary of Parent.
F2: Pursuant to the Merger Agreement, among other things, (i) each outstanding share of the common stock of the Issuer was cancelled and converted into the right to receive $9.15 in cash per share without interest and subject to deduction for any applicable withholding taxes (the "Merger Consideration") and (ii) each outstanding restricted stock award subject to time-based or performance-based vesting conditions, whether vested or unvested, held by a member of the board of directors of the Issuer (other than the Chief Executive Officer), was converted into the right to receive the Merger Consideration plus all accumulated but unpaid dividend equivalent rights with respect to such shares.
Vimeo, Inc.
Report date November 24, 2025 · Filed November 24, 2025
Section 16 reporting ended · disclosed 2025-11-24. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2025-11-24 transaction · row 1
1 source rowRow 1 · 2025-11-24 · Disposition to issuer · Disposed 44,444 · Balance 0 F1: This Form 4 reports securities transacted pursuant to the Agreement and Plan of Merger, dated as of September 10, 2025 (the "Merger Agreement"), by and among the Issuer, Bending Spoons US Inc. ("Bending Spoons US"), Bending Spoons S.p.A. and Bloomberg Merger Sub Inc., a wholly-owned subsidiary of Bending Spoons US ("Merger Sub"). On November 24, 2025 (the "Effective Time"), Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly-owned subsidiary of Bending Spoons US. F2: Consists of 44,444 shares of the Issuer's common stock, par value $0.01 per share (the "Common Stock") underlying restricted stock units ("RSUs") held by the Reporting Person. F3: Pursuant to the terms of the Merger Agreement, at the Effective Time, (i) each outstanding share of Common Stock was cancelled and automatically converted into the right to receive $7.85 in cash, without interest and subject to any applicable withholding or other taxes (the "Merger Consideration"), and (ii) each outstanding RSU, whether vested or unvested, was canceled and converted into the right to receive an amount in cash equal to (x) the total number of shares underlying such RSU, multiplied by (y) the Merger Consideration. |
Filing footnotes · ownership attribution and instrument terms
F1: This Form 4 reports securities transacted pursuant to the Agreement and Plan of Merger, dated as of September 10, 2025 (the "Merger Agreement"), by and among the Issuer, Bending Spoons US Inc. ("Bending Spoons US"), Bending Spoons S.p.A. and Bloomberg Merger Sub Inc., a wholly-owned subsidiary of Bending Spoons US ("Merger Sub"). On November 24, 2025 (the "Effective Time"), Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly-owned subsidiary of Bending Spoons US.
F2: Consists of 44,444 shares of the Issuer's common stock, par value $0.01 per share (the "Common Stock") underlying restricted stock units ("RSUs") held by the Reporting Person.
F3: Pursuant to the terms of the Merger Agreement, at the Effective Time, (i) each outstanding share of Common Stock was cancelled and automatically converted into the right to receive $7.85 in cash, without interest and subject to any applicable withholding or other taxes (the "Merger Consideration"), and (ii) each outstanding RSU, whether vested or unvested, was canceled and converted into the right to receive an amount in cash equal to (x) the total number of shares underlying such RSU, multiplied by (y) the Merger Consideration.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 01, 2026 Filed May 4, 2026 21:49 UTC | GLOBAL PAYMENTS INC GPN · Entity 3197 | GrantCommon Stock | 3,179 | $0.00 | $0.00 |
DisclosureSEC source: 0001123360-26-000063 · form4.xml · nonDerivative · entry 1 Kliphouse Kirsten Marie · CIK 0001948684 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,076 F1 · kind: Represents fully-vested shares of common stock, which were granted to the reporting person as compensation for service as a non-employee director. Read SEC document |
| February 11, 2026 Filed Feb 13, 2026 17:52 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | Exercise / conversionRestricted Stock Unit · Derivative | 897 | $0.00 | $0.00 |
DisclosureSEC source: 0000920148-26-000073 · form4.xml · derivative · entry 2 Kliphouse Kirsten Marie · CIK 0001948684 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 773 Underlying: Common Stock · 897 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock. F2 · derivative.exercise_date: The Restricted Stock Units vested fully on February 11, 2026. F2 · derivative.expiration_date: The Restricted Stock Units vested fully on February 11, 2026. F3 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| February 11, 2026 Filed Feb 13, 2026 17:52 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | Exercise / conversionCommon Stock | 897 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000920148-26-000073 · form4.xml · nonDerivative · entry 1 Kliphouse Kirsten Marie · CIK 0001948684 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,160 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock. Read SEC document |
| February 10, 2026 Filed Feb 12, 2026 16:03 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | GrantRestricted Stock Unit · Derivative | 773 | $0.00 | $0.00 |
DisclosureSEC source: 0000920148-26-000046 · form4.xml · derivative · entry 1 Kliphouse Kirsten Marie · CIK 0001948684 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,670 Underlying: Common Stock · 773 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock. F2 · derivative.exercise_date: The Restricted Stock Units vest fully on February 10, 2027. F2 · derivative.expiration_date: The Restricted Stock Units vest fully on February 10, 2027. F3 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| November 24, 2025 Filed Nov 24, 2025 16:10 UTC | Vimeo, Inc. VMEO · Entity 72624 | Disposition to issuerCommon Stock | 44,444 | $7.85 | $348,885.40 |
DisclosureSEC source: 0001837686-25-000129 · wk-form4_1764018599.xml · nonDerivative · entry 1 Kliphouse Kirsten Marie · CIK 0001948684 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · kind: This Form 4 reports securities transacted pursuant to the Agreement and Plan of Merger, dated as of September 10, 2025 (the "Merger Agreement"), by and among the Issuer, Bending Spoons US Inc. ("Bending Spoons US"), Bending Spoons S.p.A. and Bloomberg Merger Sub Inc., a wholly-owned subsidiary of Bending Spoons US ("Merger Sub"). On November 24, 2025 (the "Effective Time"), Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly-owned subsidiary of Bending Spoons US. F2 · shares: Consists of 44,444 shares of the Issuer's common stock, par value $0.01 per share (the "Common Stock") underlying restricted stock units ("RSUs") held by the Reporting Person. F3 · shares: Pursuant to the terms of the Merger Agreement, at the Effective Time, (i) each outstanding share of Common Stock was cancelled and automatically converted into the right to receive $7.85 in cash, without interest and subject to any applicable withholding or other taxes (the "Merger Consideration"), and (ii) each outstanding RSU, whether vested or unvested, was canceled and converted into the right to receive an amount in cash equal to (x) the total number of shares underlying such RSU, multiplied by (y) the Merger Consideration. F3 · price: Pursuant to the terms of the Merger Agreement, at the Effective Time, (i) each outstanding share of Common Stock was cancelled and automatically converted into the right to receive $7.85 in cash, without interest and subject to any applicable withholding or other taxes (the "Merger Consideration"), and (ii) each outstanding RSU, whether vested or unvested, was canceled and converted into the right to receive an amount in cash equal to (x) the total number of shares underlying such RSU, multiplied by (y) the Merger Consideration. Read SEC document |
| August 26, 2025 Filed Aug 26, 2025 16:05 UTC | Dun & Bradstreet Holdings, Inc. DNB · Entity 76079 | Disposition to issuerCommon Stock | 53,579 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-25-083071 · tm2524251-9_4seq1.xml · nonDerivative · entry 1 Kliphouse Kirsten Marie · CIK 0001948684 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · kind: Pursuant to that certain Agreement and Plan of Merger (as amended from time to time, the "Merger Agreement") dated as of March 23, 2025 by and among the Issuer, Denali Intermediate Holdings, Inc., ("Parent"), and Denali Buyer, Inc., a direct wholly owned subsidiary of Parent ("Merger Sub"), Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly owned subsidiary of Parent. F2 · price: Pursuant to the Merger Agreement, among other things, (i) each outstanding share of the common stock of the Issuer was cancelled and converted into the right to receive $9.15 in cash per share without interest and subject to deduction for any applicable withholding taxes (the "Merger Consideration") and (ii) each outstanding restricted stock award subject to time-based or performance-based vesting conditions, whether vested or unvested, held by a member of the board of directors of the Issuer (other than the Chief Executive Officer), was converted into the right to receive the Merger Consideration plus all accumulated but unpaid dividend equivalent rights with respect to such shares. Read SEC document |
| July 01, 2025 Filed Jul 2, 2025 16:05 UTC | Vimeo, Inc. VMEO · Entity 72624 | GrantCommon Stock | 44,444 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001837686-25-000076 · wk-form4_1751486702.xml · nonDerivative · entry 1 Kliphouse Kirsten Marie · CIK 0001948684 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,444 F1 · shares: Represents a grant of restricted stock units with respect to shares of the Issuer's Common Stock that vests in two equal installments on the first two anniversaries of July 1, 2025. F1 · price: Represents a grant of restricted stock units with respect to shares of the Issuer's Common Stock that vests in two equal installments on the first two anniversaries of July 1, 2025. Read SEC document |
| April 25, 2025 Filed Apr 29, 2025 20:43 UTC | GLOBAL PAYMENTS INC GPN · Entity 3197 | GrantCommon Stock | 3,173 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-012738 · form4.xml · nonDerivative · entry 1 Kliphouse Kirsten Marie · CIK 0001948684 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,897 F1 · kind: Represents fully-vested shares of common stock, which were granted to the reporting person as compensation for service as a non-employee director. Read SEC document |
| March 10, 2025 Filed Mar 12, 2025 17:07 UTC | Dun & Bradstreet Holdings, Inc. DNB · Entity 76079 | GrantCommon Stock | 23,810 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-003314 · doc4.xml · nonDerivative · entry 1 Kliphouse Kirsten Marie · CIK 0001948684 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,579 F1 · shares: Grant of restricted common stock vesting 100% on the first anniversary of the date of grant. Read SEC document |
| February 11, 2025 Filed Feb 13, 2025 13:17 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | GrantRestricted Stock Unit · Derivative | 897 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-004513 · form4.xml · derivative · entry 1 Kliphouse Kirsten Marie · CIK 0001948684 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 897 Underlying: Common Stock · 897 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. ("LHI") Common Stock. F2 · derivative.exercise_date: The Restricted Stock Units vest fully on February 11, 2026. F2 · derivative.expiration_date: The Restricted Stock Units vest fully on February 11, 2026. Read SEC document |
| February 06, 2025 Filed Feb 10, 2025 13:44 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | Exercise / conversionRestricted Stock Unit · Derivative | 944 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-003704 · form4.xml · derivative · entry 2 Kliphouse Kirsten Marie · CIK 0001948684 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 944 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock. F2 · derivative.exercise_date: The Restricted Stock Units vested fully on February 6, 2025. F2 · derivative.expiration_date: The Restricted Stock Units vested fully on February 6, 2025. Read SEC document |
| February 06, 2025 Filed Feb 10, 2025 13:44 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | Exercise / conversionCommon Stock | 944 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-003704 · form4.xml · nonDerivative · entry 1 Kliphouse Kirsten Marie · CIK 0001948684 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,263 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock. Read SEC document |
| April 26, 2024 Filed Apr 30, 2024 20:55 UTC | GLOBAL PAYMENTS INC GPN · Entity 3197 | GrantCommon Stock | 1,846 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-013652 · form4.xml · nonDerivative · entry 1 Kliphouse Kirsten Marie · CIK 0001948684 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,724 F1 · kind: Represents fully-vested shares of common stock, which were granted to the reporting person as compensation for service as a non-employee director. Read SEC document |
| March 11, 2024 Filed Mar 12, 2024 20:10 UTC | Dun & Bradstreet Holdings, Inc. DNB · Entity 76079 | GrantCommon Stock | 19,139 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-004178 · doc4.xml · nonDerivative · entry 1 Kliphouse Kirsten Marie · CIK 0001948684 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,769 F1 · shares: Grant of restricted common stock vesting 100% on the first anniversary of the date of grant. Read SEC document |
| February 07, 2024 Filed Feb 8, 2024 17:46 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | Exercise / conversionRestricted Stock Unit · Derivative | 947 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-003888 · form4.xml · derivative · entry 3 Kliphouse Kirsten Marie · CIK 0001948684 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 944 Underlying: Common Stock · 947 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F4 · derivative.exercise_date: The Restricted Stock Units vested fully on February 7, 2024. F4 · derivative.expiration_date: The Restricted Stock Units vested fully on February 7, 2024. Read SEC document |
| February 07, 2024 Filed Feb 8, 2024 17:46 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | Exercise / conversionCommon Stock | 947 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-003888 · form4.xml · nonDerivative · entry 1 Kliphouse Kirsten Marie · CIK 0001948684 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,319 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. Read SEC document |
| February 06, 2024 Filed Feb 8, 2024 17:46 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | GrantRestricted Stock Unit · Derivative | 944 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-003888 · form4.xml · derivative · entry 2 Kliphouse Kirsten Marie · CIK 0001948684 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,891 Underlying: Common Stock · 944 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F2 · derivative.exercise_date: The Restricted Stock Units vest fully on February 6, 2025. F2 · derivative.expiration_date: The Restricted Stock Units vest fully on February 6, 2025. F3 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| October 26, 2023 Filed Oct 30, 2023 20:24 UTC | GLOBAL PAYMENTS INC GPN · Entity 3197 | GrantCommon Stock | 878 | $104.37 | $91,636.86 |
DisclosureSEC source: 0001127602-23-026361 · form4.xml · nonDerivative · entry 1 Kliphouse Kirsten Marie · CIK 0001948684 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 878 F1 · kind: Represents fully-vested shares of common stock, which were granted to the reporting person as compensation for service as a non-employee director. Read SEC document |
| October 12, 2023 Filed Oct 16, 2023 12:43 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | Exercise / conversionRestricted Stock Unit · Derivative | 372 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-025848 · form4.xml · derivative · entry 2 Kliphouse Kirsten Marie · CIK 0001948684 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 947 Underlying: Common Stock · 372 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F2 · derivative.exercise_date: The Restricted Stock Units vested fully on October 12, 2023. F2 · derivative.expiration_date: The Restricted Stock Units vested fully on October 12, 2023. F3 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Amount includes an additional 137 Restricted Stock Units resulting from the final adjustment ratio calculated pursuant to the terms of the Employee Matters Agreement by and between Laboratory Corporation of America Holdings and Fortrea Holdings Inc. Read SEC document |
| October 12, 2023 Filed Oct 16, 2023 12:43 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | Exercise / conversionCommon Stock | 372 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-23-025848 · form4.xml · nonDerivative · entry 1 Kliphouse Kirsten Marie · CIK 0001948684 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 372 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. Read SEC document |
| August 04, 2023 Filed Aug 7, 2023 17:34 UTC | Dun & Bradstreet Holdings, Inc. DNB · Entity 76079 | GrantCommon Stock | 10,630 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-008054 · doc4.xml · nonDerivative · entry 1 Kliphouse Kirsten Marie · CIK 0001948684 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,630 F1 · shares: Grant of restricted common stock vesting 100% on the first anniversary of the date of grant Read SEC document |
| February 07, 2023 Filed Feb 9, 2023 17:25 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | GrantRestricted Stock Unit · Derivative | 849 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-004128 · form4.xml · derivative · entry 1 Kliphouse Kirsten Marie · CIK 0001948684 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,182 Underlying: Common Stock · 849 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F2 · derivative.exercise_date: The Restricted Stock Units vest fully on February 7, 2024. F2 · derivative.expiration_date: The Restricted Stock Units vest fully on February 7, 2024. F3 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| October 12, 2022 Filed Oct 14, 2022 18:19 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | GrantRestricted Stock Unit · Derivative | 333 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-023933 · form4.xml · derivative · entry 1 Kliphouse Kirsten Marie · CIK 0001948684 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 333 Underlying: Common Stock · 333 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F2 · derivative.exercise_date: The Restricted Stock Units vest fully on October 12, 2023. F2 · derivative.expiration_date: The Restricted Stock Units vest fully on October 12, 2023. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.